New Call Center Helps Ovarian Cancer Patients Cope With Challenges of Diagnosis
L'Oreal Paris and Ovarian Cancer Research Fund team up with CancerCare to launch “Hope Line” for women diagnosed with ovarian cancer.
New York, September 1, 2009 —Women with ovarian cancer can now find immediate assistance to better cope with their diagnosis by calling 877-OV-HOPE-1 (877-684-6731), a new, free telephone counseling and referral service launched today by a unique partnership: L'Oreal Paris and its charitable partner, the Ovarian Cancer Research Fund (OCRF), and CancerCare, a national non-profit which provides free counseling and education services to individuals and families affected by cancer.
“Any cancer diagnosis is a frightening and stressful experience that can be difficult to cope with,” noted Rosalie Canosa, director of program services for CancerCare. “When the diagnosis is ovarian cancer, too many women have no place to turn for help with the emotional and practical impact of their situation.”
Ovarian cancer is the eighth most common cancer among U.S. women. This year, approximately 22,000 women will be diagnosed, and nearly 15,000 will lose their lives to the disease, according to the National Cancer Institute. While five-year survival rates exceed 90 percent in early-stage diagnoses, there is no effective early-stage test for the disease, which often is not diagnosed until it reaches an advanced stage, when it is far more difficult to treat successfully.
“Now, with the L'Oreal Paris OCRF Hope Line, women facing ovarian cancer can have their questions answered and find the resources they require to ensure they receive the best care possible,” said Canosa.
“We at L'Oreal Paris are deeply committed to providing tangible hope for women battling ovarian cancer,” said Karen T. Fondu, president of the L'Oreal Paris Division of L'Oreal USA, Inc. “With the L'Oreal Paris OCRF Hope Line, we hope to continue to work to improve the five-year survival rate for women and provide support along the way.”
“OCRF and our dedicated corporate partner, L'Oreal Paris, have been working together for over 12 years to empower women, and to give them hope when they face a diagnosis of ovarian cancer,” said Elizabeth Howard, CEO of OCRF. “By joining forces with CancerCare and creating the call center, we are all better able to help women across the United States.”
L'Oreal Paris and OCRF generously funded the Hope Line, which is staffed by CancerCare’s professional oncology social workers. The Hope Line operates Monday through Friday, 9 a.m. to 5 p.m. Eastern Time.
Call the L'Oreal Paris OCRF Hope Line at 877-OV-HOPE-1 (877-684-6731).
About L'Oreal Paris
The L'Oreal Paris Brand Division of L'Oreal USA, Inc. is a total beauty care company that combines the latest in technology with the highest in quality for the ultimate in luxury beauty at mass. The L'Oreal Paris brand encompasses the four major beauty categories—haircolor, haircare, skincare and cosmetics—and includes such well-known brands as Preference and Excellence haircolors; VIVE Pro, Studio Line, and L'Oreal Kids haircare; Revitalift, Age Perfect, Skin Genesis, Sublime Bronze and Men’s Expert skincare; Colour Riche, True Match, Bare Naturale, Infallible cosmetics collections, a portfolio of mascara including Voluminous, Double Extend and Telescopic among many others, and the HIP High Intensity Pigments line.
L'Oreal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L'Oreal Paris made a long-term commitment to raising awareness and funds for ovarian cancer. To date, L'Oreal Paris has helped raise more than $18 million dollars to further research and build awareness with fundraising efforts such as the L'Oreal Legends Gala and L'Oreal’s annual “Color of Hope” cosmetics collection. For more information, please visit www.lorealcolorofhope.com.
About the Ovarian Cancer Research Fund
OCRF is the leading independent organization in the U.S. dedicated to advancing ovarian cancer research. OCRF was founded in 1994 by Sol Schreiber to honor the memory of his wife Ann, a distinguished public administrator, and her courageous five-year battle with ovarian cancer. Under the leadership of Liz Tilberis, the beloved late editor-in-chief of Harper’s Bazaar, OCRF gained national prominence as an organization committed to changing the course of this deadly disease. Since 1998, OCRF has awarded over $30 million in grants to researchers across the country. For more information, visit www.ocrf.org or call 212-268-1002.